Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Psychopharmacology Bulletin, 2018, v. 48, n. 4, p. 62
- By:
- Publication type:
- Article
Works matching AU Earley, Willie R.
Results: 12
1
2
A Randomized, Double-blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder.
- Published in:
- Psychopharmacology Bulletin, 2012, v. 45, n. 1, p. 5
- By:
- Publication type:
- Article
3
The efficacy of cariprazine on function in patients with bipolar depression: a post hoc analysis of a randomized controlled trial.
- Published in:
- Current Medical Research & Opinion, 2021, v. 37, n. 9, p. 1635, doi. 10.1080/03007995.2021.1932446
- By:
- Publication type:
- Article
4
Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2022, v. 18, p. 995, doi. 10.2147/NDT.S348143
- By:
- Publication type:
- Article
5
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum].
- Published in:
- Neuropsychiatric Disease & Treatment, 2021, v. 17, p. 1481, doi. 10.2147/NDT.S316858
- By:
- Publication type:
- Article
6
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies.
- Published in:
- Neuropsychiatric Disease & Treatment, 2021, v. 17, p. 957, doi. 10.2147/NDT.S301225
- By:
- Publication type:
- Article
7
A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder.
- Published in:
- Neuropsychiatric Disease & Treatment, 2014, v. 10, p. 201, doi. 10.2147/NDT.S50248
- By:
- Publication type:
- Article
8
Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.
- Published in:
- World Journal of Biological Psychiatry, 2014, v. 15, n. 2, p. 155, doi. 10.3109/15622975.2013.842654
- By:
- Publication type:
- Article
9
EXTENDED RELEASE QUETIAPINE FUMARATE IN MAJOR DEPRESSIVE DISORDER: ANALYSIS IN PATIENTS WITH ANXIOUS DEPRESSION.
- Published in:
- Depression & Anxiety (1091-4269), 2012, v. 29, n. 7, p. 574, doi. 10.1002/da.21970
- By:
- Publication type:
- Article
10
LUMATEPERONE IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER WITH ANXIOUS DISTRESS AND MIXED FEATURES.
- Published in:
- 2025
- By:
- Publication type:
- Abstract
11
LUMATEPERONE TREATMENT FOR MAJOR DEPRESSIVE EPISODES WITH MIXED FEATURES IN MAJOR DEPRESSIVE DISORDER AND BIPOLAR I OR BIPOLAR II DISORDER.
- Published in:
- International Journal of Neuropsychopharmacology, 2025, v. 28, p. i18, doi. 10.1093/ijnp/pyae059.033
- By:
- Publication type:
- Article
12
Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study.
- Published in:
- Bipolar Disorders, 2020, v. 22, n. 4, p. 372, doi. 10.1111/bdi.12852
- By:
- Publication type:
- Article